IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.110
AS - Asia 1.116
EU - Europa 782
SA - Sud America 198
AF - Africa 197
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.062
SG - Singapore 495
CN - Cina 391
IT - Italia 302
IE - Irlanda 191
BR - Brasile 169
CI - Costa d'Avorio 147
KR - Corea 85
DE - Germania 71
UA - Ucraina 49
RU - Federazione Russa 48
CA - Canada 35
VN - Vietnam 34
IN - India 27
SN - Senegal 25
GB - Regno Unito 24
FI - Finlandia 19
HK - Hong Kong 19
NL - Olanda 17
CZ - Repubblica Ceca 15
NG - Nigeria 14
BD - Bangladesh 11
JP - Giappone 9
MX - Messico 9
PL - Polonia 9
AR - Argentina 8
CH - Svizzera 8
FR - Francia 8
IQ - Iraq 8
ID - Indonesia 7
PE - Perù 6
TR - Turchia 6
ZA - Sudafrica 6
CO - Colombia 5
SE - Svezia 5
EC - Ecuador 4
UZ - Uzbekistan 4
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
GR - Grecia 3
KG - Kirghizistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
ES - Italia 2
IL - Israele 2
LB - Libano 2
MA - Marocco 2
SA - Arabia Saudita 2
TH - Thailandia 2
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PK - Pakistan 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.407
Salva come PNG Salva come JPEG
Città #
Santa Clara 466
Dallas 411
Singapore 348
Dublin 191
Chandler 179
Hefei 170
Abidjan 147
Chicago 106
Ashburn 97
Seoul 84
Los Angeles 78
Boardman 68
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
Beijing 44
Andover 38
Catania 38
Nanjing 28
Bremen 26
Dakar 25
Des Moines 24
Hong Kong 18
Toronto 18
Milan 17
Saint Petersburg 17
New York 15
Wilmington 15
Abuja 14
Lappeenranta 14
São Paulo 14
Brno 13
Rome 12
Council Bluffs 11
San Francisco 11
Washington 11
Brooklyn 10
Hanoi 10
Ho Chi Minh City 10
Nanchang 9
Tokyo 9
Warsaw 8
Amsterdam 7
Frankfurt am Main 6
Redwood City 6
Shenyang 6
Arequipa 5
Genoa 5
Hebei 5
Messina 5
Munich 5
Palermo 5
Rio de Janeiro 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Ankara 4
Baghdad 4
Bernareggio 4
Changsha 4
Chennai 4
Columbus 4
Dhaka 4
Dong Ket 4
Misterbianco 4
Mumbai 4
Pune 4
Stockholm 4
The Dalles 4
Atlanta 3
Bari 3
Bishkek 3
Brussels 3
Charlotte 3
Curitiba 3
Falls Church 3
Favara 3
Goiânia 3
Guangzhou 3
Jaraguá do Sul 3
Jiaxing 3
Mascalucia 3
Mexico City 3
Montreal 3
Naples 3
Ottawa 3
Pinhais 3
Reggio Emilia 3
San Giorgio a Cremano 3
Seattle 3
Altamura 2
Ansbach 2
Asunción 2
Baku 2
Bangkok 2
Basel 2
Belo Horizonte 2
Birmingham 2
Totale 3.250
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 92
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 86
Serum YKL-40 in children with asthma 82
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 81
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 81
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 80
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 79
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 79
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 78
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 78
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 76
Lung clearance index: A new measure of late lung complications of cancer therapy in children 76
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 75
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 74
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 73
Cetirizine use in childhood: An update of a friendly 30-year drug 73
Lactoferrin: Cytokine modulation and application in clinical practice 72
Hypertransaminasemia in children is not always as simple as it seems 72
Minor pulmonary malformations in a child 71
Exhaled breath temperature in astmatic children 70
HMGB1 values and response to HBV vaccine in children with celiac disease 70
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 69
Liver disease in Cystic Fibrosis: an update 68
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 67
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 66
Severe Kawasaki disease in a 3-month-old patient: a case report. 65
Biomarkers in pediatric lung diseases including cystic fibrosis 65
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 65
Antihistamines in children and adolescents: A practical update 62
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 61
Severe disease in Cystic Fibrosis and fecal calprotectin levels 60
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 60
Genetic disorders of surfactant deficiency and neonatal lung disease 60
Novel therapeutic targets for allergic airway disease in children 59
Antihistamines: ABC for the pediatricians 59
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 58
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 58
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 57
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 57
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 57
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 57
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 55
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 55
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 55
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 55
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 54
Lung clearance index for evaluation of late complications of cancer therapy in children 53
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 53
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 52
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 51
The immunomodulatory role of vitamin D in respiratory diseases 51
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 50
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 50
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 49
Lower airway microbiota 49
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 47
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 46
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 45
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 45
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 45
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 45
Upper and lower airways diseases in childhood 45
Type 2 inflammation in cystic fibrosis: New insights 45
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 43
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 43
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 42
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 42
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 41
Protracted bacterial bronchitis: more to know 40
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 39
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 39
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 38
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 38
Nasal microbiome in chronic rhinosinusitis 35
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 35
The role of skin infections in atopic dermatitis in children 33
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 28
Pidotimod in allergic diseases 27
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 27
Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes 1
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics 1
Oral immunotherapy in children with allergic diseases: past, present and future 1
Totale 4.536
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.672
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 12 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20261.250 265 330 595 60 0 0 0 0 0 0 0 0
Totale 4.536